2023-02-09
On the morning of February 8th, MRKarePharma held the project completion ceremony in Xiongxing Industrial Park, High-tech Zone, Qingyuan City, Guangdong Province. gempex, as the GMP consultant for this project, was honored to be invited to attend this activity.
MRKarePharma is a wholly owned subsidiary of Guangzhou KemRocMed Pharmaceutical. MRKarePharma is a joint venture between Guangzhou KemRocMed Pharmaceutical Co., Ltd. and Polyrocks Chemical Co., Ltd. (equity company) in Qingyuan, Guangdong Province. It is mainly used for the research and development and industrial production of innovative drugs for the treatment of pulmonary heart disease. At present, the first high-activity product has completed the early laboratory validation and pilot study, and is scheduled to be put into production within this year.
"As the GMP partner of Guangzhou KemRocMed Pharmaceutical Co., LTD., gempex is very proud to join the project of MRKarePharma and provide the company with GMP consulting and implementation services." Said Ralf Gengenbach, the CEO and general manager of gempex China. "We will definitely provide the largest GMP service support for M MRKarePharma with professional and high quality service".
The project completion ceremony was attended by Ms. Tracy Feng, Vice General Manager of gempex China and Liven Liang, the GMP expert of gempex. Together with the participants, they visited the manufacturing workshop and inspection department of MRKarePharma, and participated in the forum after the visit.
